According to an article published by Foxnews entitled " FDA approves new oral MS drug, Tecfidera" the following information reveals just how big the market is for NRF2 activating medications and supplements. Tecfidera has been FDA approved to treat just one disease,...read more
Although there is no treatment that will cure Multiple Sclerosis, there are three oral medications approved by the FDA to be a first-line treatment to slow down the progression of the disease. Dimethyl Fumarate (Tecfidera, Biogen Idec) joins fingolimod (Gilenya) and...read more
English: This slide shows the global prevalence of multiple sclerosis. Deutsch: Geographische Verteilung der Multiple Sklerose Česky: Geografické rozšíření roztroušené sklerózy (Photo credit: Wikipedia) In a previous post entitled, "Multiple Sclerosis,...read more
Tylenol is a brand name the US public is well aware of, (elsewhere is it commonly known as Paracetamol). It is advertised as a pain killer, fever reducer and commonly used to reduce the symptoms of allergies, cold, coughs and flu. As far as pain reliever market goes,...read more
As a consumer of numerous vitamins and supplements over the years I would frequently start and stop consuming various supplements based on the recommendations of a Herbologist friend of mine. I used to suffer from seasonal allergies and was constantly looking for a...read more
Are you born to run? It's that time of year to focus on goals to achieve or resolutions to keep. It doesn't matter if you are professional athlete or just a weekend warrior, we all want to improve our performance. A research study conducted by Physiological Genomics...read more
Our mission is to provide an impartial review of the emerging research regarding Nrf2 activation.
We welcome the involvement of those who have published peer review studies in this field.
Should you wish to contact us, please leave a message using the adjacent form.